About Voltron Therapeutics
Voltron Therapeutics is a private company based in New York, New York. It has reported $9,362,119 raised in four offerings on Form D since July 2021. Its chief executive is Patrick Gallagher.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 28, 2022 | Nov 9, 2022amended Nov 9, 2023 | $3,210,680target not set | 63 | $50,963 | Equity, Debt, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 3, 2022 | Jun 16, 2022 | $300,000of $5.0M target | 1 | $300K | Equity, Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 19, 2021 | Sep 1, 2021 | $2,502,011of $12.0M target | 36 | $69,500 | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 31, 2019 | Jul 13, 2021 | $3,349,428fully sold | 49 | $68,356 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, four offerings | $9,362,119 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Voltron Therapeutics's Form D filed Nov 9, 2023.
ME
PK
Paul Korner
Director
JA
AZ
MD
Matthew Duffy
President and director
Also a director at Aerwave Medical and Algorithm Sciences and a president, treasurer, secretary and director at PD Theranostics.
PG
Patrick Gallagher
Chief Executive Officer and director
Also a director at Aerwave Medical and Algorithm Sciences and a chief executive officer and director at PD Theranostics.